RxDoctor Payments DataLook up a doctor →

Nader Oskooilar

Psychiatry · Newport Beach, CANPI 1336144872

Payments from drug & device makers

$3,027,028in general payments, 2019–2025

Across 757 payments — averaging $3998.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$816K
  • Eli Lilly$421K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$275K
  • Supernus Pharmaceuticals, Inc.$246K
  • Genentech, Inc.$229K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$228K
  • plus $811K from 14 others
$306,194in research payments, 2019–2025

Across 28 payments — averaging $10,935 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arbor Pharmaceuticals, Inc.$161K
  • Pfizer$122K
  • Eli Lilly$23K

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,027,028 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →